Ann: Quarterly Activities Report and Appendix 4C - Mar-2025 Qtr, page-72

Slide #4 of the quarterly report says: "Execute toward breakeven" by June 2025.
I would suggest this doesn't mean reach breakeven but provide evidence that breakeven is achievable within the cash balance time frame.
That to me means a steady and discernible decrease in cash expenditure from increasing revenue and decreasing costs.
Both those aims were present but not at a scale that would signal the market that it is achievable within the time frame I suggested above.
That could change quickly given a couple of good quarters.
If they can land a few multi unit contracts and get Q sales above 50 watch the re-rate.
I was hoping we'd see some evidence of that this quarter but alas!! So it all comes down to the next quarter, she's sprouted the lead volume for two quarters and has publicly stated this quarter we should see greater conversion.
She's staked her position out now so she has to deliver or I think her position should be questioned.
For now, I still have confidence, she's building a team and tweaking the platform, I also like her expanding into Heart failure.
Next quarter will tell the story but I hope we get an announcement regarding coverage in Texas and California or a multi unit contract in the mean time to put a floor int he price.
If I wasn't in this already I'd take a pretty serious punt on a good quarter going forward, but I'm already underwater and don't like averaging down until an upward trend is in place.